Literature DB >> 3279302

Biochemical fundamentals of Parkinson's disease.

P Riederer, W D Rausch, B Schmidt, P Kruzik, C Konradi, E Sofić, W Danielczyk, M Fischer, E Ogris.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3279302

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN： 0027-2507


× No keyword cloud information.
  11 in total

Review 1.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 2.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 3.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

4.  Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.

Authors:  F Marzatico; C Café; M Taborelli; G Benzi
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

Review 5.  Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms.

Authors:  Daniela Berg
Journal:  Neurochem Res       Date:  2007-04-28       Impact factor: 3.996

6.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

7.  Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.

Authors:  Wei Zhang; Zhao-fen Yan; Jun-hua Gao; Li Sun; Xi-yan Huang; Zhuo Liu; Shu-yang Yu; Chen-Jie Cao; Li-jun Zuo; Ze-Jie Chen; Yang Hu; Fang Wang; Jau-shyong Hong; Xiao-min Wang
Journal:  Mol Neurobiol       Date:  2013-11-26       Impact factor: 5.590

8.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

Review 9.  Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.

Authors:  P Riederer; C Monoranu; S Strobel; T Iordache; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2021-10-12       Impact factor: 3.575

Review 10.  Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Authors:  Daniela Berg; Helmine Hochstrasser; Katherine J Schweitzer; Olaf Riess
Journal:  Neurotox Res       Date:  2006-01       Impact factor: 3.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.